Low-risk DCIS patients may safely skip radiotherapy after surgery, study finds

The potential for breakthrough cell and gene therapies to transform healthcare cannot be underestimated. Some of the most complex and sophisticated medical treatments in development

Not want­i­ng to be left out in the cold, Mer­ck now plans to pur­sue GLP-1 com­bi­na­tion ther­a­pies amid grow­ing ex­cite­ment about the lu­cra­tive po­ten­tial of a drug class that